Intracytoplasmic Sperm Injection (ICSI)
Last updated: March 2026 · Medically reviewed by Dr. Adnan Jabbar
Intracytoplasmic Sperm Injection (ICSI) is a specialised form of IVF in which a single sperm is injected directly into a mature egg using a microscopic glass needle. It was developed to overcome severe male factor infertility and achieves fertilisation rates of 70–85% per injected egg regardless of sperm quality.
70–85%
Fertilisation rate per injected egg (ASRM, 2023)
50%+
Of all IVF cycles worldwide now use ICSI (ESHRE, 2022)
~40%
Male factor contribution to couple infertility globally (WHO, 2023)
When is ICSI used?
ICSI is the treatment of choice when the male partner has severe oligospermia (very low sperm count), poor motility (asthenospermia), abnormal morphology (teratospermia), or azoospermia requiring surgical sperm retrieval. It is also used when a previous conventional IVF cycle had low or failed fertilisation.
Importantly, large randomised controlled trials — including a Cochrane Review (2021) — have found no benefit to using ICSI over conventional IVF in couples with normal sperm. ICSI should not be used routinely; it is a targeted solution for a specific clinical problem.
Related terms
Frequently asked questions about ICSI
What does ICSI stand for?
Is ICSI better than conventional IVF?
What fertilisation rate does ICSI achieve?
Can ICSI be used with surgically retrieved sperm?
Is ICSI right for you?
Dr. Adnan Jabbar offers free initial consultations via WhatsApp.
Ask about ICSI on WhatsApp